NIH St. John’s Wort Study In Mild Depression To Enroll 300 Participants
This article was originally published in The Tan Sheet
Executive Summary
A total of 300 subjects suffering from minor depression are being enrolled in a four-year NIH study on the safety and efficacy of St. John's wort for treatment of the condition
You may also be interested in...
St. John’s Wort Multi-Center Trial In Mild Depression Underway
A multi-center clinical trial on St. John's wort in mild depression is underway with $4 mil. in funding from three National Institutes of Health divisions, according to the National Center for Complementary and Alternative Medicine
NIH St. John's Wort Study Focus On Major Depression Criticized By CRN Panel
A National Institutes of Health-funded study on St. John's wort and major depression likely will show a "very poor response rate" because the botanical is indicated only for treatment of mild to moderate depression, a former NIH official said at a Council for Responsible Nutrition press briefing June 25.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC